Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

NephroGenex Inc

+ Add to Watchlist


8.2200 USD 0.0600 0.74%

As of 17:20:00 ET on 03/03/2015.

Company Profile for NephroGenex Inc (NRX)

NephroGenex, Inc. develops novel drugs for the treatment of kidney disease. The Company is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients.

Contact Information

NephroGenex Inc

79 TW Alexander Drive
Building 4401, Suite290
Research Triangle Park, NC 27709-4188
United States
Phone: 1-609-986-1780
Fax: 1-609-275-5610

Key Executives for NephroGenex Inc (NRX)

Pierre LegaultChief Executive OfficerJ Wesley FoxPres/Chief Scientific Officer
John P HamillCFO/Treasurer/SecretaryBob PetersonVP:Product Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil